NASDAQ : CLDX

Celldex Therapeutics, Inc. — Company profile

Healthcare · Biotechnology · United States

Last price 30.1 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 2.36B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Company profile

Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic antibodies for patients with severe inflammatory, allergic, autoimmune, and other diseases. The company’s drug candidates include monoclonal and bispecific antibodies designed to address mast cell mediated diseases for which available treatments are inadequate. It develops clinical programs, including Barzolvolimab (CDX-0159), a monoclonal antibody that specifically binds the KIT receptor and potently inhibits its activity for treating chronic urticarias, prurigo nodularis, eosinophilic esophagitis, and atopic dermatitis; and CDX-622, a bispecific candidate for inflammatory diseases, which targets two complementary pathways that drive chronic inflammation, potently neutralizing the alarmin thymic stromal lymphopoietin and depleting mast cells through stem cell factor starvation. Celldex Therapeutics, Inc. is headquartered in Hampton, New Jersey.

Details

NameCelldex Therapeutics, Inc.
SectorHealthcare
IndustryBiotechnology
Employees198
Ipo Date2008-03-10
CeoAnthony Marucci
CountryUnited States
ExchangeNASDAQ
Fiscal YearJanuary - December
Reporting CurrencyUSD
IsinUS15117B2025
Cusip15117B202
Cik0000744218
Sic2835
Stock TypeCommon Stock

Key executives

NameTitle
Anthony S. Marucci M.B.A.Founder, President, Chief Executive Officer and Director
Dr. Tibor Keler Ph.D.Founder, Chief Scientific Officer and Executive Vice President
Sam Martin CPASenior Vice President, Chief Financial Officer, Secretary and Treasurer
Elizabeth CrowleyChief Product Development Officer and Senior Vice President
Dr. Margo Heath-Chiozzi M.D.Senior Vice President of Regulatory Affairs
Prof. Joseph P. Schlessinger Ph.D.Co-Founder and Member of Scientific Advisory Board
Sarah CavanaughSenior Vice President of Corporate Affairs and Administration
Freddy A. Jimenez Esq.Senior Vice President and General Counsel
Dr. Ronald A. Pepin Ph.D.Chief Business Officer and Senior Vice President
Dr. Diane C. Young M.D.Senior Vice President and Chief Medical Officer

Contact

AddressPerryville III Building, Suite 220, Hampton, New Jersey 08827, United States
Phone908 200 7500
Websitehttps://www.celldex.com